Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation - Kolijn, D; Pabel, S; Tian, Y
Cardiovasc Res. 2020 May 12:cvaa123